Plaque on the surface of the tooth consists of a bacterial film that produces acids as a by-product of its metabolism. To be specific, certain bacteria within the oral diseases such as dental caries and periodontal disease, should be considered as consequences of ecologically driven imbalances of oral microbial biofilms.The ecological disruption resulting from antibiotic treatment frequently results in secondary infections or other negative clinical consequences. To address this problem, researchers have recently developed a new class of pathogen-selective molecules, called specifically (or selectively) targeted antimicrobial peptides (STAMPs), and based on the fusion of a species-specific targeting peptide domain with a wide-spectrum antimicrobial peptide domain.
Introduction:
Dental caries (tooth decay) is one of the most prevalent and~o~tlydiseases in the United States and throughout the world (Evans and Kleinman, 2000) . Although the ultimate manifestation of the disease is the dissolution of tooth structure, the biological nature ofthe disease is a microbial infection caused primarily by the cariogenic bacterium Streptococcus mutans (S. mutans ).' Dental plaque as a microbial biofilm is defined as thediverse community of micro-organisms found on the toothsurfaces, embedded in an extra cellular matrix of hostand microbial polymers. The streptococci are the pioneerstrains in plaque formation and rriutans streptococci arethe main etiological agent of dental plaque and caries.During dental plaque formation, some oral bacteria are early colonizers that express biochemical components allowing them to adhere effectively to specific tissues (teeth or periodontal tissue). The later colonizers often contain components that enable them to adhere to the early colonizers, bringing competitive advantages. Within an established dental plaque, specific bacterial species are often found located adjacent to each other or mixed together to form unique structures that may confer adherence or growth advantages.
In complex biofilms, it is not merely the presence of a single organism, but the interactions between and among the biofilm residents that are crucial and determine the properties of a biofilm. As an example, in the presence of nearby base-producing bacteria, S. mutans in dental plaque may not be pathogenic. Thus, for dental caries, it is now recognized that this disease results not solely because of the presence of S. mutans or any single organism in dental plaque. Rather, it is the interaction of multiple acidproducing organisms such as S. mutans with other biofilm residents (Kleinberg, 2002; Marsh, 2005)3
Most current dental therapies are focused on eradicatinz the entire dental plaque via mechanical removal or broadspectrum antimicrobial treatments. However, the improved under-standing of oral microbial ecology, especially the importance of the balance between oral pathogens and commensal residents, has prompted interest in novel approaches focused on selective pathogen inhibition and modulation ofthe microbial composition of dental plaque to control pathogenesis.'
Stamps:
A new class of targeted antimicrobials, called specifically (or selectively) targeted antimicrobialpeptides (STAMPs),constructed from short peptides that canbe chemically synthesized with high yields in vitro studies. STAMPs haveincreased killing potency, selectivity, and kinetics against targetedbacteria."
A typical STAMP molecule consists of two functionally independent moieties conjoined in a linear peptide sequence: a non-specific antimicrobial peptide serves as the killing moiety while a species-specific binding peptide comprises the targeting moiety that provides specific binding to a selected pathogen and facilitates the targeted delivery of the attached antimicrobial peptide. STAMPs have shown effective eliminationof S. mutans from a mixed-species environment without affecting closely related non-cariogenic oral streptococci.'
. Sources Of Stamps:
A number of derivatives from natural products, such as cranberry constituents, plant lectins, crude extracts of Morusalba leaves, and fractions of barley coffee, have been shown to be effective against biofilm formation ofS. mutans. These substances can regulate the activities of surface-anchored virulence factors glucosyltransferase and fructosyltransferase. Numerous small molecules, including anthraquinones, apigenin, tt-famesol, chitosan, and 7-epiclusianone, have been characterized and shown to have antibiofilm activity toward S. mutans .However, none of them were reported to possess selectivity against S. mutans biofilms. The prevention and treatment approaches based on these existing methods tend to disturb the ecological balance between pathogens and commensal residents in the oral cavity, which may lead to more severe infections. Therefore, it is necessary to develop a new approach which can selectively inhibit pathogenic bacteria and biofilms. To achieve this selectivity goal, pursuit of small molecules based upon nitrogen-dense marine alkaloids, have designed numerous derivatives of marine natural products based primarily on the 2-aminoimidazole (2-AI) scaffold and have shown that these compounds are potent inhibitors of biofilm formation by both Gram-positive and Gramnegative bacteria albeit the underlying mechanisms of biofilm inhibition/ dispersion are still under investigation.' Antimicrobial Action:
Ithas been hypothesized thatthe rapid bactericidal activity of such peptides is based on aninitial binding to lipopolysaccharide (LPS) from gram-negative bacteria'although the details of this mechanism appear to vary widely .Previous observations have indicated the critical role of the general hydrophobic and cationic character of AMP function, including the significant contribution of aromatic Tryptophan and cationic Arginine residues found in many AMPs. Despite their small size (most are less than 50 amino acids), secondary structure also appears to play an important role in activity: certain linear AMPs can adopt an a-helical or b-strand confirmation upon interaction with hydrophobic environments such as detergents or lipid vesicles that mimic bacterial membranes, suggesting that these conformational changes are necessary for antimicrobial function. Both species can persist in a biofilm when inoculated at the same time, but given the chance to establish a biofilm first, either species can preclude colonization of the other.STAMP technology is a potentially useful method for removing S. mutans from saliva, thus establishing an oral flora that can help prevent or reduce further infection ofS. rnutans.' C 16G2, a novel synthetic specifically targeted antimicrobial peptide with specificity for S. mutans. C 16G2 consists of as. mutans-selective 'targeting region' comprised of a fragment from S. mutans competence stimulation peptide (CSP) conjoined to a 'killing region' consisting of a broad-spectrum antimicrobial peptide (G2). In vitro studies have indicated that C16G2 has robust efficacy and selectivity for S. mutans, and not other oral bacteria, and affects targeted bacteria within seconds of contact.. C16G2 rinse usage was associated with reductions in plaque and salivary S. mutans, lactic acid production, and enamel demineralization. The impact on total plaque bacteria was minimal.
Other Choice Of Agents, Approaches Replacement therapy has been researched for over 30 years, with cariogenic bacteria being modified to make them less acidogenic,while keeping their colonizationresistance properties (Hillmanand Socransky, 1987) . Much of this work was started in the periodwhen most attention was given to the arch criminal of caries, Streptococcus mutans. 9 Animal experiments involving lactate-dehydrogenase deficientand ureolytic S. mutans strains have shown promising results in caries prevention (Clancy et al., 2000) . In the former case, the approach is directed against single microbial species. However, one should not disregard the role of other microorganisms, such as non-mutans acidogenic streptococci, in thecaries process in humans.'
The use of probiotics, very established in the treatment of intestinal diseases, is now also considered for oraldiseases (Nase et al., 2001; Twetman and Stecksen-Blicks, 2008).Most attention is given to the lactobacillus species, in particularthose that produce bacteriocins. Obviously, this should be donewith great care, since lactobacilli also produce acids.
Biofilm research has disclosed that bacteria in a biofilm interact through peptides to regulate their metabolism. Quorum-sensing peptides are secreted, and when these exceed threshold concentrations, bacteria modify their physiology. Quorum-sensing peptide-likemolecules have been tested to upset bacterial 'societies' (Aharoniet al., 2008). For each of these promising new approaches, the questions remain how agents can be made cost-effective and how they can be formulated into usable produc.ts.'0
